Live news related to GENSIGHT BIOLOGICS stock (FR0013183985): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on GENSIGHT BIOLOGICS mainly cover M&A activity. The stock trades at €0,08 on Euronext Paris, down 1,44% at the last update. This page lists the articles published on GENSIGHT BIOLOGICS stock to track the share price, company announcements and any item likely to influence market perception.
The French National Agency for the Safety of Medicines and Health Products has granted a compassionate access for GS010/LUMEVOQ, GenSight Biologics' g…
